BeOne Medicines (ONC) Inventory Average (2017 - 2026)

BeOne Medicines (ONC) has reported Inventory Average for 10 consecutive years, with $707.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 41.77% year-over-year to $707.1 million in Q2 2026; TTM through Jun 2026 was $707.1 million, a 41.77% increase from a year earlier, with the FY2025 full-year figure at $551.6 million, up 21.08% from the prior year.
• Inventory Average was $707.1 million for Q2 2026 at BeOne Medicines, up from $644.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $707.1 million in Q2 2026 and troughed at $244.1 million in Q1 2022.
• A 5-year average of $419.8 million and a median of $434.6 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 200.9% in 2022 and rose 12.01% in 2025, its largest moves.
• Over 5 years, Inventory Average stood at $286.6 million in 2022, then grew by 27.87% to $366.5 million in 2023, then increased by 26.41% to $463.3 million in 2024, then increased by 23.01% to $570.0 million in 2025, then gained by 24.06% to $707.1 million in 2026.
• The last three Inventory Average figures came in at $707.1 million (Q2 2026), $644.9 million (Q1 2026), and $570.0 million (Q4 2025), per Business Quant data.